Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?

E-ISSN： 1996-3181|13|3|418-428

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.3, 2014-04, pp. : 418-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological Mechanisms Linking Alzheimer’s Disease and Type-2 Diabetes Mellitus

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1192-1201

Bentham Science Publishers

Access to resources Recommend Favorite

Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1432-1439

Bentham Science Publishers

Access to resources Recommend Favorite

Major Depressive Disorder and Type II Diabetes Mellitus: Mechanisms Underlying Risk for Alzheimer’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1740-1749

Bentham Science Publishers

Access to resources Recommend Favorite

Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 10, 2015-01 ,pp. : 853-870

Bentham Science Publishers

Access to resources Recommend Favorite

Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H. Kennedy F.P. Garratt K.N.

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite